The School of Medicine Department of Pathology is now recruiting for a Director of Finance. This position provides strategic direction and leadership for the control of financial accounting operations through the development, enhancement, and guidance of its various functions and staff members. The selected candidate will review, analyze and interpret all financial and budgetary reports to ensure timely and effective decision making by senior management. Collaborates with upper level administrators and other directors within the business unit and throughout the campus in order to ensure the delivery of high quality service.
UMB offers a comprehensive and competitive benefits package to eligible employees. This position receives an annual leave package starting with 22 accrued vacation days, 14 floating and observed holidays, 15 sick days, and 3 personal days; comprehensive health insurance and retirement options; professional learning and development opportunities; flexible schedules and teleworking options; and tuition remission for employees and their dependents at any of the University System of Maryland schools.
Provide general direction and leadership for all aspects of departmental functions in order to maintain their efficient operation.
Partner with upper level administrators and other directors on a regular basis in setting strategic goals/objectives and budgets, and/or in fostering improvements in policies/procedures for the entire department.
Ensure efficient recruitment/interviewing and training functions to continually review strengths and weaknesses in maintaining a staff of well-trained, highly involved, and motivated employees.
Maintain and nurture effective communication and partnerships throughout the campus by conferring with business unit and campus leadership on issues pertaining to the promotion and understanding of the departmental functions.
Proactively represent the department through participation in campus meetings and special projects, as well as UMB on an external basis with USM headquarters and other system-wide units.
Performs other duties as assigned.
Education: Bachelors in finance, accounting, business administration, public administration or an equivalent field is required.
Experience: Seven (7) years spent progressively building a background in the financial and business operations of a department or business unit. Knowledge of research administration, pre- and post-award, preferred.
Supervisory: Five (5) years of experience at a management/leadership level.
Other: No substitution of experience for minimum education requirement.
Hiring Range: Commensurate with education and experience.
If accommodations are needed, contact Staffing & Career Services at 410-706-2606, Monday – Friday, 8:30am – 4:30pm EST. Maryland Relay can be accessed by dialing 711 (in-state) or 1-800-735-2258.
UMB is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected Veteran status, age, or any other characteristic protected by law or policy.
Job: Reg or CII Exempt Staff - E1222H Employee Class: Exempt Regular Full Time/Part Time: Full Time Shift: Day Job Organization: School of Medicine - Pathology Job Posting: Feb 10, 2020 Unposting Date: Mar 11, 2020, 11:59:00 PM
Telecommuting is allowed.
Internal Number: 20000060
About University of Maryland School of Medicine
The University of Maryland School of Medicine is the first public and fifth oldest medical school in the United States. On the University of Maryland, Baltimore campus, the School of Medicine serves as the foundation for a large academic health center that combines medical education, biomedical research, patient care and community service. In fiscal year 2018, the School of Medicine was ranked 8th among public medical schools and 26th among all medical schools in total grants and contracts expenditures. Our scientists and clinicians received $537 million in grants and contracts in FY 2018.